Show simple item record

dc.contributor.authorNyeko, Richard
dc.contributor.authorGeriga, Fadhil
dc.contributor.authorAngom, Racheal
dc.contributor.authorKambugu, Joyce Balagadde
dc.date.accessioned2022-11-04T08:53:35Z
dc.date.available2022-11-04T08:53:35Z
dc.date.issued2022
dc.identifier.urihttp://ir.lirauni.ac.ug/xmlui/handle/123456789/442
dc.description.abstractBackground: There have hardly been any reported cases of children presenting with Kaposi sarcoma as a second malignancy following treatment for acute lymphoblastic leukemia outside a transplant setting. Case presentation: We report a case of a 5-year-old boy of Bantu origin, which, to our knowledge, could be only the second reported case of oral–visceral Kaposi sarcoma after acute lymphoblastic leukemia treatment. The patient presented with a 1-month history of progressive, non-painful, soft tissue oral mass, 1 month after completing treatment for high-risk acute lymphoblastic leukemia. He was successfully treated for Kaposi sarcoma on a two-drug regimen (bleomycin and vincristine) with good clinical response. Conclusion: Visceral Kaposi sarcoma as a second malignancy may occur after pediatric acute lymphoblastic leukemia treatment, but its rarity makes it unlikely to raise suspicion among clinicians, thus precluding early diagnosis and treatment. We recommend routine evaluation for Kaposi sarcoma lesions in children undergoing long-term surveillance following treatment for childhood acute leukemiaen_US
dc.publisherJournal of Medical Case Reportsen_US
dc.subjectKaposi sarcomaen_US
dc.subjectAcute lymphoblastic leukemiaen_US
dc.subjectSecondary malignancyen_US
dc.subjectHHV-8en_US
dc.subjectPediatric case reporten_US
dc.titleOral–visceral iatrogenic Kaposi sarcoma following treatment for acute lymphoblastic leukemia: a case report and review of the literatureen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record